Last Updated: 17 Sep 2024
Executive Summary
Kindly MD, Inc. (KDLY) is a healthcare and healthcare data company that provides direct health care services to patients integrating prescription medicine and behavioral health services. The company's stock price is currently trading at $1.27, which is below its 52-week high of $4.20. Kindly MD has a market capitalization of $7.55 million and a trailing twelve-month revenue of $30.97 million. The company is not profitable, with a trailing twelve-month EBITDA of -$19.83 million.
Company Overview
Kindly MD was founded in 2017 and is headquartered in Salt Lake City, Utah. The company provides a range of healthcare services, including primary care, mental health care, and medication management. Kindly MD also offers a telemedicine platform that allows patients to access care from anywhere.
Fundamental Analysis
Kindly MD's financial performance has been mixed in recent quarters. The company's revenue has grown in the past year, but its profitability has declined. Kindly MD is not currently profitable, and its EBITDA margin is -1.62%. The company's book value is $0.738 per share.
Technical Analysis
Kindly MD's stock price has been trending down in recent months. The stock is currently trading below its 50-day and 200-day moving averages. The stock's relative strength index (RSI) is 30.57, which indicates that the stock is oversold.
Short Term Outlook
The short-term outlook for Kindly MD is mixed. The company's stock price has been trending down in recent months, and the stock is currently trading below its 50-day and 200-day moving averages. However, the stock's RSI is oversold, which could indicate that the stock is due for a rebound.
Long Term Outlook
The long-term outlook for Kindly MD is positive. The company's revenue has grown in the past year, and the company is expanding its range of services. Kindly MD is also well-positioned to benefit from the growing demand for healthcare services.
Analyst Recommendations
Analysts are mixed on Kindly MD. Some analysts believe that the company's stock is undervalued, while others believe that the company's profitability challenges will continue to weigh on the stock price. Overall, the consensus analyst rating for Kindly MD is "hold."
